Expert Panel: Peritoneal Mesothelioma & HIPEC
Learn everything you need to know about peritoneal mesothelioma and HIPEC in our online presentation exclusively for peritoneal patients and their families. Top mesothelioma specialist Dr. Edward Levine and 16-year survivor Tamron Little discuss how HIPEC works, what to expect from the procedure, and tips to expedite the recovery process.
Learn everything you need to know about peritoneal mesothelioma and HIPEC in our online presentation exclusively for peritoneal patients and their families. Top mesothelioma specialist Dr. Edward Levine and 16-year survivor Tamron Little discuss how HIPEC works, what to expect from the procedure, and tips to expedite the recovery process.
-
Dr. Edward LevineSurgical Oncologist and Mesothelioma Specialist -
Tamron LittleMesothelioma Survivor and Writer -
Sean Marchese, MS, RNOncology Medical Writer and Registered Nurse
What You’ll Learn From the Webinar
- Benefits of HIPEC versus other peritoneal mesothelioma treatments
- Factors that impact eligibility & the types of patients seeing the best results
- What to expect before, during & after HIPEC
- Tips to expedite recovery time
- Success rates & long-term impact on survival time & quality of life
You’ll also receive access to the free Q&A session our experts hosted after the presentation.
Featuring Three Mesothelioma Experts
Dr. Levine is a renowned peritoneal mesothelioma specialist at Wake Forest Baptist Medical Center. Peritoneal mesothelioma survivor Tamron Little offers a unique perspective on the lessons she learned after her diagnosis. Registered nurse Sean Marchese helps patients learn about the latest mesothelioma treatments.-
Dr. Edward LevineDr. Edward Levine is the chief of surgical oncology services at the Wake Forest Baptist Health Comprehensive Cancer Center in Winston-Salem, North Carolina. He has been nationally recognized in the use of HIPEC in combination with cytoreductive surgery for peritoneal surface malignancies. -
Tamron LittleTamron Little was diagnosed with peritoneal mesothelioma in 2007 at just 21 years of age. She underwent successful cytoreductive surgery, hyperthermic intraperitoneal chemotherapy (HIPEC) and intensity modulated radiation therapy. After more than a decade of surviving with mesothelioma, Tamron shares her experiences to support people diagnosed with this rare cancer. -
Sean Marchese, MS, RNSean Marchese has planned and led experimental clinical trials in oncology involving immunotherapy, chemotherapy, radiation therapy and tumor treating fields. He is a registered nurse with more than 10 years in clinical experience and more than six years in clinical research. Sean has been a member of the American Nurses Association since 2017.
